Core Laboratories N.V.
CLB · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $26 | $31 | $22 | $19 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $125 | $128 | $131 | $127 |
| Inventory | $58 | $60 | $59 | $59 |
| Other Curr. Assets | $8 | $8 | $6 | $11 |
| Total Curr. Assets | $227 | $238 | $229 | $227 |
| Property Plant & Equip (Net) | $152 | $153 | $155 | $154 |
| Goodwill | $100 | $100 | $99 | $99 |
| Intangibles | $6 | $6 | $6 | $6 |
| Long-Term Investments | $0 | $0 | $0 | $5 |
| Tax Assets | $71 | $70 | $0 | $70 |
| Other NC Assets | $36 | $35 | $102 | $30 |
| Total NC Assets | $364 | $364 | $363 | $364 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $591 | $602 | $592 | $590 |
| Liabilities | – | – | – | – |
| Payables | $37 | $42 | $38 | $35 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $7 | $8 | $0 | $12 |
| Deferred Revenue | $7 | $9 | $10 | $9 |
| Other Curr. Liab. | $9 | $9 | $14 | $8 |
| Total Curr. Liab. | $96 | $105 | $104 | $98 |
| LT Debt | $114 | $125 | $124 | $126 |
| Deferred Rev, NC | $0 | $0 | $29 | $31 |
| Deferred Tax Liab, NC | $10 | $11 | $10 | $14 |
| Other NC Liab. | $52 | $52 | $21 | $21 |
| Total NC Liab. | $218 | $230 | $228 | $235 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $53 | $54 | $56 | $43 |
| Total Liabilities | $314 | $335 | $332 | $333 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $174 | $160 | $0 | $150 |
| AOCI | -$6 | -$6 | -$6 | -$6 |
| Other Equity | $0 | $0 | $259 | $0 |
| Total Equity | $271 | $261 | $253 | $252 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $6 | $6 | $6 | $6 |
| Total Liab. & Tot. Equity | $591 | $602 | $592 | $590 |
| Net Debt | $88 | $93 | $102 | $107 |